LeafCann Group is an Australian-based, federally licensed botanical extracts company with a strong and innovative pipeline of GMP manufactured consumer and prescription products in new categories that are being released during 2021. A world-class management team and leading international professionals on their advisory board bring decades of combined experience working with and in regulated Medical Cannabis Schemes, pharmaceutical and botanical extracts development, and consumer sales. LeafCann’s promise is to provide the highest quality, consistent product, at affordable prices, creating great value for patients and reliable dosing for physicians.